ロード中...
Use of a Novel Artificial Intelligence Platform on Mobile Devices to Assess Dosing Compliance in a Phase 2 Clinical Trial in Subjects With Schizophrenia
BACKGROUND: Accurately monitoring and collecting drug adherence data can allow for better understanding and interpretation of the outcomes of clinical trials. Most clinical trials use a combination of pill counts and self-reported data to measure drug adherence, despite the drawbacks of relying on t...
保存先:
| 出版年: | JMIR Mhealth Uhealth |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
JMIR Publications
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5340925/ https://ncbi.nlm.nih.gov/pubmed/28223265 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2196/mhealth.7030 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|